N/A
N=103
USS Training to Improve Social Function in People With Psychosis
Psychosis
Bottom Line
View on ClinicalTrials.gov: NCT04557124 ↗Enrolled (actual)
103
Serious AEs
11.7%
Results posted
Mar 2025
Primary outcome: Primary: Social Functioning Scale (SFS) Change — 1.28; 0.19; 1.56; 0.32 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- USS (Behavioral); MovingForward (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Sep 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Social Functioning Scale (SFS) Change |
1.28; 0.19; 1.56; 0.32 | — |
| SECONDARY Social Skills Performance Assessment (SSPA) Change |
0.01; -0.11; 0.00; -0.03 | — |
Summary
Psychotic spectrum disorders (PSD) are associated with poor social function. By doing this study, the investigators hope to learn which of two different types of 2-month long training courses is more effective in improving day-to-day interactions and quality of life.
Eligibility Criteria
Inclusion Criteria
- Veteran with diagnosis of psychotic disorder (e.g. schizophrenia, schizoaffective disorder, delusional disorder, psychosis NOS, etc);
- psychiatrically stable (30 or more days since last hospitalization/change in psychiatric medication)
- fluent in English
- able to provide legal written informed consent
Exclusion Criteria
- current substance use disorder
- developmental disability
- severe, uncorrected auditory/visual impairment
- diagnosis of medical or neurological illness known to impair brain function including dementia, presence of seizures, history of head trauma with loss of consciousness > 1hr, or clear cognitive sequelae from other illness or injury
- currently enrolled in another treatment study targeting, or expected to impact, functioning.
Data sourced from ClinicalTrials.gov (NCT04557124). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.